Juno Therapeutics is a biopharmaceutical company founded in 2013 through a collaboration of ... In December 2014 the company signed an agreement with Opus Bio, Inc for a chimeric antigen receptor (CAR-T) cell product candidate ...
Sep 4, 2018 ... As part of the settlement, anyone who acquired Juno stock between June 4, 2016 and Nov. ... admission of wrongdoing on the part of Juno or the executives named in the lawsuit, including Bishop, Juno's current chief medical ...
Juno Therapeutics is proud to announce it is now a Celgene company. If you would like ... If you would like information about Celgene Corporation, please visit :.
We're on a quest to radically change the course of medicine by aligning our investments in research, manufacturing & people to change the way we treat ...
Juno Therapeutics, Inc. is offering shares of common stock. ...... or the medical diagnosis of seriously debilitating diseases or life-threatening diseases and those ...
Identify the previous filing by registration statement number, or the Form or .... The Board of Directors (the "Board") of Juno Therapeutics, Inc. (referred to herein ..... of Vanderbilt University Medical Center and advises BlackThorn Therapeutics.
Juno Therapeutics, Inc. develops cell-based cancer immunotherapies based on its ... B cell malignancies in patients relapsed or refractory to standard therapies.
NEW YORK & SEATTLE, Aug 4th, 2016 – Eureka Therapeutics, Inc. and Memorial ... “We are pleased to work with Juno Therapeutics on developing CAR T ... Memorial Sloan Kettering specialists are leaders in biomedical research and in ... Juno's ability to obtain, maintain, or protect intellectual property rights related to its ...
Aug 31, 2018 ... Juno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two ... Meet Juno Therapeutics, Inc.